Pattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelines

Journal of Clinical Psychopharmacology

Volumn 34, Issue 5, 2014, Pages 577-587

  Baek, Ji Hyun ^a,b   Ha, Kyooseob ^a,c   Yatham, Lakshimi N ^d   Chang, Jae Seung ^a   Ha, Tae Hyon ^a   Jeon, Hong Jin ^b   Hong, Kyung Sue ^b   Chang, Sung Man ^e   Ahn, Yong Min ^f   Cho, Hyun Sang ^g   Moon, Eunsoo ^h   Cha, Boseok ⁱ   Choi, Jung Eun ^j   Joo, Yeon Ho ^k   Joo, Eun Jeong ^l   Lee, Se Young ^a   Park, Yunseong ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Kyungpook National University School of Medicine   (South Korea)

^f Seoul National University   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Pusan National University School of Medicine   (South Korea)

ⁱ Gyeongsang National University School of Medicine   (South Korea)

^j Seoul Eunpyeong Hospital   (South Korea)

^k Asan Medical Center   (South Korea)

^l Eulji General Hospital   (South Korea)

more..

Author keywords

bipolar disorders; guideline; pharmacotherapy; prescription pattern

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ASENAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; ESCITALOPRAM; ICOSAPENTAENOIC ACID; LAMOTRIGINE; LITHIUM; MILNACIPRAN; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PRAMIPEXOLE; QUETIAPINE; RILUZOLE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL PRACTICE; DRUG SUBSTITUTION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; BIPOLAR DISORDER; CLINICAL TRIAL; COMBINATION DRUG THERAPY; EPIDEMIOLOGY; MULTICENTER STUDY; PROTOCOL COMPLIANCE; SOUTH KOREA; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; REPUBLIC OF KOREA;

EID: 84907423762     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000175     Document Type: Article

References (44)

1. Grunze H, Vieta E, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WF-SBP) guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85-116.
2. NICE. The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. London: National Collaborating Center for Mental Health; 2006.
3. Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66:870-886.
4. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disord. 2009;11:225-255.
5. Suppes T, Rush AJ, Dennehy EB, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3): Clinical results for patients with a history of mania. J Clin Psychiatry. 2003;64:370-382.
6. Altinbas K, Smith D, Oral ET. Adherence to Turkish psychiatric association guideline for bipolar depression treatment in a specialized mood disorders outpatient unit. Psychiatr Danub. 2011;23:189-193.
7. Blanco C, Laje G, Olfson M, et al. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry. 2002;159:1005-1010.
8. Evans-Lacko SE, Dosreis S, Kastelic EA, et al. Evaluation of guideline-concordant care for bipolar disorder among privately insured youth. Prim Care Companion J Clin Psychiatry [serial online]. 2010. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947537/. Accessed May 20, 2012.
9. Hayes J, Prah P, Nazareth I, et al. Prescribing trends in bipolar disorder: Cohort study in the United Kingdom THIN primary care database 1995-2009. PLoS One. 2011;6:e28725.
10. Ghaemi SN, Hsu DJ, Thase ME, et al. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv. 2006;57:660-665.
11. Kessing LV, Hellmund G, Geddes JR, et al. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: Observational nationwide register-based cohort study. Br J Psychiatry. 2011;199:57-63.
12. Bramness JG, Groholt B, Engeland A, et al. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007Va prescription database study. J Affect Disord. 2009;117:208-211.
13. Goodwin GM. Bipolar depression and treatment with antidepressants. Br J Psychiatry. 2012;200:5-6.
14. Baldessarini R, Henk H, Sklar A, et al. Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and adherence. Psychiatr Serv. 2008;59:1175-1183.
15. Frangou S, Raymont V, Bettany D. The Maudsley Bipolar Disorder Project. A survey of psychotropic prescribing patterns in bipolar I disorder. Bipolar Disord. 2002;4:378-385.
16. Morgan S, Hanley G, Cunningham C, et al. Ethnic differences in the use of prescription drugs: A cross-sectional analysis of linked survey and administrative data. Open Med. 2011;5:e87-e93.
17. Ng CH, Easteal S, Tan S, et al. Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities. Prog Neuropsychopharmacol Biol Psychiatry.. 2006;30:953-957.
18. Baek JH, Park DY, Choi J, et al. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history. J Affect Disord. 2011;131:59-67.
19. Benazzi F. Bipolar II disorder : Epidemiology, diagnosis and management. CNS Drugs. 2007;21:727-740.
20. Min K, Bahk W, Yoon B, et al. Korean Medication Algorithm for Bipolar Disorder 2010: Introduction. Korean J Psychopharmacol. 2011;22:171-182.
21. American Psychiatric Association. Quick Reference to the American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Arlington, VA: American Psychiatric Publishing Inc; 2006.
22. Hirschfeld RMA. Guideline Watch: Practice Guideline for the Treatment of Patients With Bipolar Disorder. Arlington, VA: American Psychiatric Publishing Inc; 2006.
23. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85-116.
24. Goldberg JF, Brooks JO 3rd, Kurita K, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: Findings from the STEP-BD. J Clin Psychiatry. 2009;70:155-162.
25. Greil W, Haberle A, Haueis P, et al. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. J Affect Disord. 2012;136:534-542.
26. Schatzberg AG, Cole JO, Debattista C. Manual of Clinical Psychopharmacology. Arlington, VA: American Psychiatric Publishing Inc; 2010.
27. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67:26-36.
28. Alda M, Yatham LN. Is monotherapy as good as polypharmacy in long-term treatment of bipolar disorder? Can J Psychiatry. 2009;54:719-725.
29. Goodwin FK, Whitham EA, Ghaemi SN. Maintenance treatment study designs in bipolar disorder: Do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers? CNS Drugs. 2011;25:819-827.
30. Peters AT, Nierenberg AA. Stepping back to step forward: Lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2011;72:1429-1431.
31. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161:1537-1547.
32. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry. 2001;62:565-569.
33. Post RM, Leverich GS, Altshuler LL, et al. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry. 2012;73:924-930.
34. Salvadore G, Quiroz JA, Machado-Vieira R, et al. The neurobiology of the switch process in bipolar disorder: A review. J Clin Psychiatry. 2010;71:1488-1501.
35. Wolfsperger M, Greil W, Rossler W, et al. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord. 2007;99:9-17.
36. Benazzi F, Akiskal H. Irritable-hostile depression: Further validation as a bipolar depressive mixed state. J Affect Disord. 2005;84:197-207.
37. Fountoulakis KN, Kontis D, Gonda X, et al. Treatment of mixed bipolar states. Int J Neuropsychopharmacol. 2012;15:1015-1026.
38. Young AH, Hammond JM. Lithium in mood disorders: Increasing evidence base, declining use? Br J Psychiatry. 2007;191:474-476.
39. Smith LA, Cornelius V, Warnock A, et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: A systematic review of randomized controlled trials. Bipolar Disord. 2007;9:394-412.
40. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465.
41. Spanemberg L, Massuda R, Lovato L, et al. Pharmacological treatment of bipolar depression: Qualitative systematic review of double-blind randomized clinical trials. Psychiatr Q. 2012;73:924-930.
42. Bauer MS, Biswas K, Kilbourne AM. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. Am J Psychiatry. 2009;166:1244-1250.
43. Dennehy EB, Bauer MS, Perlis RH, et al. Concordance with treatment guidelines for bipolar disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder. Psychopharmacol Bull. 2007;40:72-84.
44. Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC1ational Academy Press; 2001.